Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TTD vs GSK✓SelectedUSD · GSKTTD vs GSK performance historyLatest closeAs of-8.10%11/20
Stock and ETF performance explorer

TTD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+356.2%
GSK return
+97.4%
Excess return
+258.8%
Maximum drawdown
-91.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.1%-0.1%-8.0%-8.1%
7D-14.7%-5.3%-9.3%-13.4%
30D+6.3%-3.7%+9.9%+7.3%
3M+0.5%-7.3%+7.7%+2.4%
6M-36.3%-4.2%-32.1%-35.9%
YTD-64.8%+0.9%-65.6%-65.5%
1Y-65.1%+7.3%-72.4%-66.6%
3Y-80.1%+52.7%-132.9%-83.9%
5Y-87.6%+40.1%-127.7%-89.8%
All+356.2%+97.4%+258.8%+205.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling